article thumbnail

Realm of Caring Appoints Research Director to Oversee Groundbreaking Cannabis Data Registry and Medical Studies

Cannabis Law Report

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior. About Realm of Caring.

Data 105
article thumbnail

This free cannabis hotline answers all of your plant questions

The Cannigma

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Medical Study Reports Reduced Depression and Anxiety Symptoms With Low Doses of CBD

Cannabis Law Report

The longitudinal study, using data gathered from RoC’s Observational Research Registry (ORR), showed that individuals who initiated use of artisanal cannabidiol (CBD) products or continued use of CBD products at follow-up endorsed significant reductions in both anxiety and depression, improved sleep, and less pain compared with those not using CBD.

CBD 52
article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. More recently, MDMA therapy has inched closer to FDA approval. 10] In the meantime, FDA has approved some requests for compassionate use. [11].

article thumbnail

Study: Marijuana Legalization Associated With Decreased Sales of Sleep Aids

The Joint Blog

Legal access to marijuana is associated with a decline in the sales of over-the-counter (OTC) sleep aid medications, according to a new study published in the journal Complementary Therapies in Medicine. – The negative association between cannabis access and sleep aid sales suggests a consumer preference for cannabis. .”

Sleep 49
article thumbnail

Psychedelic Science Leader Eleusis to Become Public Company in Merger with Silver Spike Acquisition Corp. II

Cannabis Law Report

Merger also to support nationwide expansion of Eleusis’s subsidiary Andala, which manages in-network drug therapy clinics targeting the “last mile” challenge of psychedelic care delivery to address a potential $7 billion U.S. Founded in 2013, Eleusis is dedicated to transforming psychedelics into medicines.

Therapy 52
article thumbnail

How cannabis affects urinary function

The Cannigma

The common understanding is that every individual has a separate and different reaction to cannabinoid-based therapy, the same is true with how it might influence individual urinary symptoms. The effects of cannabis on micturition are complex with many factors at play.